Show simple item record

dc.contributor.authorPentheroudakis, Georgeen
dc.contributor.authorMauri, D.en
dc.contributor.authorKostadima, Lidaen
dc.contributor.authorGolfinopoulos, Vassilisen
dc.contributor.authorAlexiou, G.en
dc.contributor.authorKarakatsanis, A.en
dc.contributor.authorPavlidis, Nicholasen
dc.creatorPentheroudakis, Georgeen
dc.creatorMauri, D.en
dc.creatorKostadima, Lidaen
dc.creatorGolfinopoulos, Vassilisen
dc.creatorAlexiou, G.en
dc.creatorKarakatsanis, A.en
dc.creatorPavlidis, Nicholasen
dc.date.accessioned2018-06-22T09:54:25Z
dc.date.available2018-06-22T09:54:25Z
dc.date.issued2006
dc.identifier.urihttps://gnosis.library.ucy.ac.cy/handle/7/42347
dc.description.abstractIntroduction: Despite unique tumor epidemiology and a higher cancer incidence compared to pediatric patients, adolescents and young adults have not been receiving specialized, multidisciplinary, centralized care. In an effort to emphasize this need, we present outcome and toxicity data from a reference centre. Methods: Cohort of 150 patients aged 15-30 treated for malignant tumors of lymphoid and solid organs from 1986 to 2002. Results: Patients aged 15-19 commonly had lymphomas, germ cell tumors and pediatric sarcomas, whereas those aged 20-30 experienced germ cell tumors, lymphomas, melanomas and epithelial tumors more often. Overall 5- and 10-year survival was 80%, whereas 5-year and 10-year time to treatment failure was 68% and 43.5% respectively. 24% of patients experienced persistent, late treatment-related toxicities that interfered with their normal lifestyle. Conclusion: Despite the need for specialized care, psychosocial support and enrollment in clinical trials, youngsters have not been recognized as a patient group with distinct needs. Development of «Juvenile» oncology is required. © FESEO 2006.en
dc.language.isoengen
dc.sourceClinical and Translational Oncologyen
dc.subjectGreeceen
dc.subjectArticleen
dc.subjectAntineoplastic agenten
dc.subjectAntineoplastic agentsen
dc.subjectBleomycinen
dc.subjectChlormethineen
dc.subjectCisplatinen
dc.subjectDacarbazineen
dc.subjectDoxorubicinen
dc.subjectHumanen
dc.subjectNeoplasmsen
dc.subjectPatient careen
dc.subjectPrednisoneen
dc.subjectProcarbazineen
dc.subjectVinblastineen
dc.subjectVincristineen
dc.subjectHumansen
dc.subjectAdulten
dc.subjectControlled studyen
dc.subjectFemaleen
dc.subjectMajor clinical studyen
dc.subjectOncologyen
dc.subjectCancer survivalen
dc.subjectChemotherapyen
dc.subjectOvary canceren
dc.subjectRetrospective studiesen
dc.subjectRetrospective studyen
dc.subjectTaxane derivativeen
dc.subjectSurvival analysisen
dc.subjectDisease free survivalen
dc.subjectSurvivalen
dc.subjectSurvival rateen
dc.subjectHospitalsen
dc.subjectCancer researchen
dc.subjectAdolescenten
dc.subjectOverall survivalen
dc.subjectCancer radiotherapyen
dc.subjectHodgkin diseaseen
dc.subjectNonhodgkin lymphomaen
dc.subjectColorectal canceren
dc.subjectMelanomaen
dc.subjectNeoplasmen
dc.subjectSarcomaen
dc.subjectMaleen
dc.subjectIncidenceen
dc.subjectNeurologic diseaseen
dc.subjectSide effecten
dc.subjectCancer centeren
dc.subjectStomach canceren
dc.subjectCancer incidenceen
dc.subjectLiver cell carcinomaen
dc.subjectCanceren
dc.subjectMultiple cycle treatmenten
dc.subjectLiver dysfunctionen
dc.subjectNitrosoureaen
dc.subjectProctitisen
dc.subjectXerostomiaen
dc.subjectQuality of lifeen
dc.subjectVinca alkaloiden
dc.subjectDepressionen
dc.subjectHeart diseaseen
dc.subjectKidney canceren
dc.subjectSocial supporten
dc.subjectPsychological aspecten
dc.subjectGerm cell tumoren
dc.subjectMedical specialisten
dc.subjectPatient referralen
dc.subjectLymphomaen
dc.subjectInterdisciplinary communicationen
dc.subjectUniversityen
dc.subjectStatisticsen
dc.subjectEar diseaseen
dc.subjectHeart left ventricle ejection fractionen
dc.subjectTreatment failureen
dc.subjectAdolescentsen
dc.subjectCancer epidemiologyen
dc.subjectLifestyleen
dc.subjectUniversity hospitalen
dc.subjectMedical oncologyen
dc.subjectInfertilityen
dc.subjectChildhood canceren
dc.subjectTestis canceren
dc.subjectRaynaud phenomenonen
dc.subjectSoft tissue sarcomaen
dc.subjectAcademic medical centersen
dc.subjectAmenorrheaen
dc.subjectAnus canceren
dc.subjectAzoospermiaen
dc.subjectBladder obstructionen
dc.subjectCancer care facilitiesen
dc.subjectDiagnosis related groupen
dc.subjectDiagnosis-related groupsen
dc.subjectEndocrine diseaseen
dc.subjectEpithelium tumoren
dc.subjectFemur head necrosisen
dc.subjectHealth care deliveryen
dc.subjectHealth care needen
dc.subjectJuvenile oncologyen
dc.subjectLymphedemaen
dc.subjectOsteosarcomaen
dc.subjectPatient care teamen
dc.subjectPediatricsen
dc.subjectPostoperative complicationen
dc.subjectPostoperative complicationsen
dc.subjectPsychosocial careen
dc.subjectRadiotherapyen
dc.subjectReferral and consultationen
dc.subjectSmall intestine canceren
dc.subjectSudden deathen
dc.subjectYoung adultsen
dc.title«Juvenile» oncology - A missing subspecialty. The experience of a reference cancer centreen
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1007/s12094-006-0199-1
dc.description.volume8
dc.description.issue6
dc.description.startingpage444
dc.description.endingpage449
dc.author.facultyΙατρική Σχολή / Medical School
dc.type.uhtypeArticleen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record